CorporateNovo Nordisk Seeks US Court Order to Halt Eli Lilly's Weight-Loss Drug AdsBY Outlook Business Desk
CorporateNovo Nordisk Sues Eli Lilly; Alleges Misleading Weight-Loss Drug AdvertisingBY Outlook Business Desk
CorporateUS Pharma Firm Eli Lilly Partners with Cipla to Sell Weight-loss Drug in India under Brand Name ‘Yurpeak’BY Outlook Business Desk
CorporateNovo Nordisk Rolls-out Weight-Loss Jab Wegovy In India, Prices Higher Than Lilly's MounjaroBY Outlook Business Desk
CorporateEli Lilly Says Its Anti-Obesity Pill Orforglipron Shows Promising ResultsBY Outlook Business Desk
